…%) normalised within 6 months as compared to 18/28 (64.3%) with fenofibrate. This was not significantly different between the groups (p=0.4…
fenofibrate
This drug is selected. Its supporting articles are shown below.
Articles mentioning fenofibrate
5 articles · page 1 of 1…isease, and three with familial hypercholesterolaemia. Prior to inclisiran, 11 patients (28.9%) had been treated with evolocumab and 2 pat…
…5% CI 0.454-0.945, p=0.024), were independently associated with UDCA treatment failure (IDDF2026-ABS-0398 Figure 1).Conclusions Earl…
… was recently withdrawn from the US creating a therapeutic gap. Seladelpar (SEL), approved in 2024 in the US for patients with PBC and an …
…Immunosuppression 100 (27%)• Azathioprine (38)• Budesonide (7)• Mercaptopurine (5)• Mycophenolate (40)• Prednisolone (4)• Tacrolimus (6) Prima…